BioLineRx (BLRX) Change in Acquisitions & Divestments (2013 - 2026)

BioLineRx's Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at -$7.6 million for Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to -$7.6 million; the TTM figure through Dec 2025 stood at -$36.6 million (down 39.07% YoY), while the FY2025 annual figure was -$36.6 million, down 39.07% from the prior year.
• Change in Acquisitions & Divestments for Q4 2025 stood at -$7.6 million, down from -$4.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $16.7 million in Q1 2024, with the low at -$42.0 million in Q1 2021.
• The 5-year median for Change in Acquisitions & Divestments is -$8.0 million (2021), against an average of -$12.2 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 403.98% in 2024, while the deepest fall reached 7267.19% in 2024.
• BioLineRx's Change in Acquisitions & Divestments stood at -$8.0 million in 2021, then changed by 0.0% to -$8.0 million in 2022, then sank by 321.32% to -$33.7 million in 2023, then soared by 82.82% to -$5.8 million in 2024, then tumbled by 31.53% to -$7.6 million in 2025.
• Business Quant data shows BLRX's Change in Acquisitions & Divestments at -$7.6 million in Q4 2025, -$4.2 million in Q3 2025, and -$12.5 million in Q2 2025.